Long-Term Ixekizumab Treatment Does Not Raise Risk for Cancer in Patients With Chronic Inflammatory Disease
Summary by Medscape
1 Articles
1 Articles
All
Left
Center
Right
Long-Term Ixekizumab Treatment Does Not Raise Risk for Cancer in Patients With Chronic Inflammatory Disease
Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, and axSpA, according to a pooled analysis of randomized trials.
·United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium